Raquel P. Deering

Also affiliated with Moderna Therapeutics (United States)

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “CLINICAL RESPONSES TO ODRONEXTAMAB (REGN1979): CORRELATION WITH LOSS OF CD20 EXPRESSION AS A POTENTIAL MECHANISM OF RESISTANCE AND BASELINE BIOMARKERS OF TUMOR T CELLS”.

CLINICAL RESPONSES TO ODRONEXTAMAB (REGN1979): CORRELATION WITH LOSS OF CD20 EXPRESSION AS A POTENTIAL MECHANISM OF RESISTANCE AND BASELINE BIOMARKERS OF TUMOR T CELLS

Hematological Oncology(2021)10.1002/hon.6_2880

N/A

0DataRank · unranked

1 citations

Nathalie Fiaschi, Raquel P. Deering, Ankur Dhanik, Kamil J. Cygan, W Zhang +19 more

Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma

Nature Medicine(2023)10.1038/s41591-023-02345-0

N/A

0DataRank · unranked

401 citations

Pauline Hamon, Nathalie Fiaschi, Brian Y. Soong, Matthew D. Park, Raphaël Mattiuz +48 more